---
document_datetime: 2023-09-21 18:00:40
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/optison-epar-all-authorised-presentations_en.pdf
document_name: optison-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7672146
conversion_datetime: 2025-12-15 22:17:57.221184
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Numbers      | Invented name   | Strength                                                                                                                                             | Pharmaceutical Form      | Route of administration   | Packaging    | Content   | Package sizes   |
|-----------------|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------|---------------------------|--------------|-----------|-----------------|
| EU/1/98/065/001 | Optison         | 0.19 mg/ml. 5 - 8 x 10 8 perflutren-containing microspheres with a mean diameter range of 2.5 - 4.5 μ m; equivalent to 0.19 mg perflutren gas per ml | Dispersion for injection | Intravenous use           | Vial (glass) | 3 ml      | 1 vial          |
| EU/1/98/065/002 | Optison         | 0.19 mg/ml. 5 - 8 x 10 8 perflutren-containing microspheres with a mean diameter range of 2.5 - 4.5 μ m; equivalent to 0.19 mg perflutren gas per ml | Dispersion for injection | Intravenous use           | Vial (glass) | 3 ml      | 5 vials         |